ArticleBritish journal of cancer2016

Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma.

Sari F Alhasan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.